New CMS rule will confuse patients, groups say
Hospitals sue over drug price disclosure rule.
Read more
 
FDA clears generic MS treatments
This is the agency’s first generic approvals of Gilenya.
Read more
 
Personalized treatments could increase value of cancer care
From our sister publication, Managed Healthcare Executive®: There are a lot of ideas about ways to increase the value of cancer care, but personalized treatments may be the most significant and immediate.
Read more